Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Error parsing response

9 months ago1 min read

Share

Error occurred while parsing the model response.

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

Related News

Jan 14,

2025

Akero's Efruxifermin Shows Promise in Reversing Cirrhosis Due to MASH in Phase 2b Trial

Dec 17,

2024

aTyr Pharma's Efzofitimod Shows Continued Promise in Phase 3 Pulmonary Sarcoidosis Trial

Oct 31,

2024

Vyepti (Eptinezumab) Shows Positive Phase III Results in Asian Migraine Patients

Oct 29,

2024

Ensitrelvir Shows Promise as Post-Exposure Prophylaxis for COVID-19 in Phase 3 Trial

Oct 28,

2024

Fabhalta Demonstrates Sustained Efficacy in Phase 3 Trial for C3 Glomerulopathy

Oct 16,

2024

Glaukos' Epioxa Shows Positive Phase 3 Results for Keratoconus Treatment

Oct 15,

2024

MeiraGTx's AAV-GAD Gene Therapy Shows Promise in Parkinson's Disease Phase I/II Trial

Sep 24,

2024

Nxera Pharma Partners with Shionogi for Quviviq Distribution in Japan Following Approval for Insomnia

Sep 11,

2024

Merck's Gardasil 9 Shows Positive Phase 3 Results in Japanese Males

Sep 9,

2024

Akero Therapeutics Doses First Patient in Phase 3 SYNCHRONY Outcomes Trial for MASH Cirrhosis

Sources

Viatris Announces Positive Top-line Results from Phase 3 Study of EFFEXOR® in Japanese ...

biospace.comOct 9, 2024

Viatris seeks Japan's MHLW approval for Effexor SR capsules to treat generalized anxiety disorder

pharmabiz.comApr 22, 2025

Viatris Files Supplemental New Drug Applications to Japan's Ministry of Health, Labor and ...

newsroom.viatris.comApr 21, 2025

Positive Top-line Results from Phase 3 Study of Effexor in Japanese Adults with Generalized Anxiety Disorder

drugs.comApr 9, 2025

Trending News

FDA Publishes Over 200 Drug Rejection Letters in Historic Transparency Initiative

FDA Approves First Year-Long Flea and Tick Injectable for Dogs

PDS Biotech's Novel IL-12 ADC Advances to Phase 2 Stage 2 in Metastatic Colorectal Cancer

Varda Space Industries Secures $187 Million Series C to Advance Microgravity Drug Manufacturing

FDA Issues Complete Response Letter for Ultragenyx's UX111 Gene Therapy for Sanfilippo Syndrome Type A

Pelthos Therapeutics Launches ZELSUVMI, First FDA-Approved At-Home Treatment for Molluscum Contagiosum

Arcus Biosciences' CD73 Inhibitor Quemliclustat Receives FDA Orphan Drug Designation for Pancreatic Cancer

Formycon Completes Enrollment for Keytruda Biosimilar Study, Skips Phase III Trial with FDA Approval

Wockhardt Exits US Generics Business to Focus on Novel Antibiotic Drug Discovery

XyloCor Therapeutics Initiates Phase 2b Trial for Gene Therapy XC001 in Refractory Angina

Daily Pharma Insights

Get curated, high-impact pharmaceutical news delivered to your inbox every morning.

Critical clinical trial updates & results
Regulatory approvals & strategic partnerships
Market access decisions & commercial developments

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy